Cervical cancer is the possible outcome of a genital infection with high‐risk human
papillomavirus type 16 (HPV16) and is preceded by a phase of persistent HPV infection …

Background: Population-based studies have reported a second peak of human
papillomavirus (HPV) prevalence among women> 55 years, but reasons for this U-shaped …

During the past several years, this author has been engaged in coordinating two major
multicentre trials testing optional screening tools for cervical cancer (CC) in low-resource …

ABSTRACT OBJECTIVE: To assess the prevalence of high-risk genital human
papillomavirus (HPV) infection by age group and risk factors associated. METHODS: Cross …

We have tested the safety and feasibility of a synthetic long peptide‐based HPV16‐specific
skin test to detect cellular immune responses to HPV16 E2, E6 and E7 in vivo. Women with …

Whether persistent human papillomavirus (HPV) IgG antibodies following natural infection
are protective against subsequent infection is unknown. In a cohort of 508 college women …

Se presenta una revisión sobre la relación entre el virus de papiloma humano y el cáncer
cérvicouterino, haciendo énfasis en el papel etiológico de la infección viral durante el …

The biological importance of a group of human papillomaviruses, known as high-risk human
papillomaviruses, as the key causal agent for almost all cervical cancer has now been …

OBJECTIVE: Sampling of the transformation zone (TZ) and endocervical cells (EC) has been
widely regarded as a quality indicator in cervical screening programs; however, the …

The aim of this work was to study the human papillomavirus (HPV) type-distribution in
condylomata acuminata (CA) of mainland China and to estimate the potential role of HPV …